Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BORDEN

Showing results (261-270 of 327) with videos related to

Pageof 33
Sort By:
Oncogene|October 15, 2011
G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancerV Cheriyath, M A Kuhns, B S Jacobs, et al.
Cancer|July 1, 1976
Further clinical studies with megestrol acetate in advanced breast cancerF J Ansfield, H L Davis, G Ramirez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humansM J Hawkins, E C Borden, J A Merritt, et al.
Leukemia|July 18, 2001
Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-alpha2a) plus an anthracycline-based induction regimenR V Smalley, E Weller, M J Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup StudyM K Samson, L P Wasser, E C Borden, et al.
AIDS (London, England)|March 1, 1991
2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individualsP L Witt, G T Spear, M J Lindstrom, et al.
American Journal of Clinical Oncology|August 1, 1982
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomasE C Borden, A Ash, H T Enterline, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cellsJ W Greiner, F Guadagni, D Goldstein, et al.
The New England Journal of Medicine|November 5, 1992
Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphomaR V Smalley, J W Andersen, M J Hawkins, et al.
Journal of Interferon Research|April 1, 1988
Lack of interferon production by dipyridamoleK A Havlin, A D Inglot, J K Willson, et al.
Pageof 33

Showing results (261-270 of 327) with videos related to

Sort By:
Pageof 33
Oncogene|October 15, 2011
G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancerV Cheriyath, M A Kuhns, B S Jacobs, et al.
Cancer|July 1, 1976
Further clinical studies with megestrol acetate in advanced breast cancerF J Ansfield, H L Davis, G Ramirez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humansM J Hawkins, E C Borden, J A Merritt, et al.
Leukemia|July 18, 2001
Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-alpha2a) plus an anthracycline-based induction regimenR V Smalley, E Weller, M J Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1987
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup StudyM K Samson, L P Wasser, E C Borden, et al.
AIDS (London, England)|March 1, 1991
2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individualsP L Witt, G T Spear, M J Lindstrom, et al.
American Journal of Clinical Oncology|August 1, 1982
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomasE C Borden, A Ash, H T Enterline, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cellsJ W Greiner, F Guadagni, D Goldstein, et al.
The New England Journal of Medicine|November 5, 1992
Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphomaR V Smalley, J W Andersen, M J Hawkins, et al.
Journal of Interferon Research|April 1, 1988
Lack of interferon production by dipyridamoleK A Havlin, A D Inglot, J K Willson, et al.
Pageof 33